Generian
Generian
About
Generian is building a first-in-class drug discovery pipeline of small molecule drugs to address the shortcomings of biologics and improve the patient experience by increasing convenience and access.
We strive to discover and develop small molecule therapeutics for diseases with high unmet need—specifically areas dominated by biologics. Oral, small molecule therapeutics are more economically sustainable and allow for treatment titration in a way not possible with antibodies. This approach has the potential to improve the patient experience by increasing convenience and access while reducing cost to payors.
Get Updates
from LSPA
Stay up-to-date on the latest news and events from Life Sciences PA, insights from the life sciences industry, and so much more!
Life Sciences Pennsylvania was founded in 1989 by a biotech scientist at Penn State University. Today it has grown to represent the entire life sciences industry – biotechnology and diagnostic companies, medical device companies, pharmaceutical companies, investment organizations, research institutions, and myriad service industries that support the life sciences in Pennsylvania.